Nov 14, 2024 / 10:00PM GMT
Operator
Good afternoon. Ladies and gentlemen, welcome to the Plus Therapeutics third quarter, 2024 results conference call. Before we begin, we want to advise you that over the course of the call, including any question and answer session. Forward-looking statements will be made regarding events, trends, business prospects and financial performance which may affect plus therapeutics', future operating results and financial position. All such statements are subject to risks and uncertainties including the risks and uncertainties described under the risk factors section included in Plus therapeutics', annual report on form 10-K and quarterly reports on form 10-Q filed with the Securities and Exchange Commission from time to time. Plus therapeutics advises you to review these risk factors in considering such statements. Plus therapeutics assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.
It is now my pleasure to turn the floor over to Dr Mark Hedrick Plus Therapeutics, President and Chief Executive Officer, sir
Q3 2024 Plus Therapeutics Inc Earnings Call Transcript
Nov 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers